258 related articles for article (PubMed ID: 29017655)
21. Risk factors of de novo hepatitis B virus infection in pediatric hepatitis B core antibody positive liver graft recipients under prophylactic therapy.
Dong C; Song Z; Chen J; Ma N; Meng X; Sun C; Duan K; Bi B; Wang K; Qin H; Han C; Yang Y; Zhang F; Zheng W; Gao W
J Gastroenterol Hepatol; 2020 May; 35(5):827-832. PubMed ID: 31609494
[TBL] [Abstract][Full Text] [Related]
22. Transmission of hepatitis B virus from hepatitis B core antibody-positive donors in living related liver transplants.
Uemoto S; Sugiyama K; Marusawa H; Inomata Y; Asonuma K; Egawa H; Kiuchi T; Miyake Y; Tanaka K; Chiba T
Transplantation; 1998 Feb; 65(4):494-9. PubMed ID: 9500622
[TBL] [Abstract][Full Text] [Related]
23. Safe use of livers from donors with positive hepatitis B core antibody.
Manzarbeitia C; Reich DJ; Ortiz JA; Rothstein KD; Araya VR; Munoz SJ
Liver Transpl; 2002 Jun; 8(6):556-61. PubMed ID: 12037788
[TBL] [Abstract][Full Text] [Related]
24. Active immunization to prevent de novo hepatitis B virus infection in pediatric live donor liver recipients.
Lin CC; Chen CL; Concejero A; Wang CC; Wang SH; Liu YW; Yang CH; Yong CC; Lin TS; Jawan B; Cheng YF; Eng HL
Am J Transplant; 2007 Jan; 7(1):195-200. PubMed ID: 17227568
[TBL] [Abstract][Full Text] [Related]
25. Different effect of HBV vaccine after liver transplantation between chronic HBV carriers and non-HBV patients who received HBcAb-positive grafts.
Ishigami M; Kamei H; Nakamura T; Katano Y; Ando H; Kiuchi T; Goto H
J Gastroenterol; 2011 Mar; 46(3):367-77. PubMed ID: 20835733
[TBL] [Abstract][Full Text] [Related]
26. Active immunization for prevention of De novo hepatitis B virus infection after adult living donor liver transplantation with a hepatitis B core antigen-positive graft.
Wang SH; Loh PY; Lin TL; Lin LM; Li WF; Lin YH; Lin CC; Chen CL
Liver Transpl; 2017 Oct; 23(10):1266-1272. PubMed ID: 28691231
[TBL] [Abstract][Full Text] [Related]
27. The risks of HBV infection after liver transplantation from HBc antibody positive donor to HBs antibody positive recipient.
Ikegami T; Taketomi A; Ohta R; Soejima Y; Yoshizumi T; Harada N; Shimada M; Maehara Y
Hepatogastroenterology; 2008; 55(88):2162-5. PubMed ID: 19260497
[TBL] [Abstract][Full Text] [Related]
28. Antibody titration and immune response of Iranian beta-thalassemic patients to hepatitis B virus vaccine (booster effect).
Azarkeivan A; Karimi G; Shaiegan M; Maghsudlu M; Tabbaroki A
Pediatr Hematol Oncol; 2009 Jun; 26(4):195-201. PubMed ID: 19437322
[TBL] [Abstract][Full Text] [Related]
29. Expanding the donor pool: Kidney transplantation from serum HBV DNA or HBeAg-positive donors to HBsAg-negative recipients.
Yin S; Wu L; Zhang F; Huang X; Wu J; Wang X; Lin T
Liver Int; 2023 Nov; 43(11):2415-2424. PubMed ID: 37592870
[TBL] [Abstract][Full Text] [Related]
30. [De novo hepatitis B infection after liver transplantation--evidence for the need of active hepatitis B vaccination of liver transplantation candidates].
Rambusch EG; Nashan B; Tillmann HL; Böker KH; Schlitt HJ; Maschek H; Raab R; Manns MP
Z Gastroenterol; 1998 Dec; 36(12):1027-35. PubMed ID: 10025054
[TBL] [Abstract][Full Text] [Related]
31. Use of hepatitis B core antibody-positive liver allograft in hepatitis C virus-positive and -negative recipients with use of short course of hepatitis B immunoglobulin and Lamivudine.
Jain A; Orloff M; Abt P; Kashyap R; Mohanka R; Lansing K; Kelley M; Bozorgzadeh A
Transplant Proc; 2005 Sep; 37(7):3187-9. PubMed ID: 16213345
[TBL] [Abstract][Full Text] [Related]
32. Transplantation of livers from hbc Ab positive donors into HBc Ab negative recipients: a strategy and preliminary results.
Loss GE; Mason AL; Blazek J; Dick D; Lipscomb J; Guo L; Perrillo RP; Eason JD
Clin Transplant; 2001; 15 Suppl 6():55-8. PubMed ID: 11903388
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis B virus vaccine switch program for prevention of de novo hepatitis B virus infection in pediatric patients.
Park JB; Kwon CH; Lee KW; Choi GS; Kim DJ; Seo JM; Kim SJ; Joh JW; Lee SK
Transpl Int; 2008 Apr; 21(4):346-52. PubMed ID: 18208419
[TBL] [Abstract][Full Text] [Related]
34. De novo hepatitis B virus infection developing after liver transplantation using a graft positive for hepatitis B core antibody.
Han JH; Kim DG; Na GH; Kim EY; Lee SH; Hong TH; You YK; Choi JY; Yoon SK
Ann Surg Treat Res; 2015 Sep; 89(3):145-50. PubMed ID: 26366384
[TBL] [Abstract][Full Text] [Related]
35. De Novo Hepatitis B Virus Infection After Liver Transplantation in Hepatitis B Core-positive Recipients Using Hepatitis B Core-negative Grafts.
Nugroho A; Lee KW; Kim H; Yi NJ; Suh KS
Transplant Proc; 2019 Apr; 51(3):842-844. PubMed ID: 30979473
[TBL] [Abstract][Full Text] [Related]
36. Long-term protection against hepatitis B in pediatric liver recipients can be achieved effectively with vaccination after transplantation.
Kwon CH; Suh KS; Yi NJ; Chang SH; Cho YB; Cho JY; Lee HJ; Seo JK; Lee KU
Pediatr Transplant; 2006 Jun; 10(4):479-86. PubMed ID: 16712607
[TBL] [Abstract][Full Text] [Related]
37. Kidney transplantation from hepatitis B virus core antibody-positive donors: prophylaxis with hepatitis B immunoglobulin.
Veroux M; Corona D; Ekser B; Giaquinta A; Tallarita T; De Martino C; Gentile F; Virgilio C; Gagliano M; Fiamingo P; Veroux P
Transplant Proc; 2011 May; 43(4):967-70. PubMed ID: 21620027
[TBL] [Abstract][Full Text] [Related]
38. Comparison of different immunoprophylaxis regimens after liver transplantation with hepatitis B core antibody-positive donors: a systematic review.
Saab S; Waterman B; Chi AC; Tong MJ
Liver Transpl; 2010 Mar; 16(3):300-7. PubMed ID: 20209589
[TBL] [Abstract][Full Text] [Related]
39. Effect of hepatitis B surface antibody in patients with core antibody-positive liver transplantation: a systematic review and meta-analysis.
Yang Y; Huang A; Zhao Y
Hepatol Int; 2020 Mar; 14(2):202-211. PubMed ID: 32100260
[TBL] [Abstract][Full Text] [Related]
40. High prevalence of hepatitis B-antibody loss and a case report of
Sintusek P; Posuwan N; Wanawongsawad P; Jitraruch S; Poovorawan Y; Chongsrisawat V
World J Gastroenterol; 2018 Feb; 24(6):752-762. PubMed ID: 29456414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
